Clinical Trial

A Study of Ivonescimab in People With Leiomyosarcoma

Name: A Study of Ivonescimab in People With Leiomyosarcoma — clinical trial record (NCT07516925)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side effects for people with advanced/unresectable leiomyosarcoma.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-04-01.

Trial Details

NCT Number	NCT07516925
Lead Sponsor	Memorial Sloan Kettering Cancer Center Collaborators: Summit Therapeutics
Conditions	Leiomyosarcoma
Enrollment	20 participants
Start Date	2026-04-01
Primary Completion	2029-04 (estimated)
Study Completion	2029-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-03